While his fellow members of Congress were enjoying carousel rides on the White House lawn, Rep. Chris Collins (R-N.Y.) was apparently learning the company he'd invested millions in was about to fail.
The congressman and longtime President Trump fan was a top shareholder in Innate Immunotherapeutics, and he lost $17 million when it was revealed the Australian biotech company's star drug didn't pass clinical trials. But as an Innate board member, Collins learned about the failure before it went public — and told his son to sell his shares before he suffered similar losses, court filings released Wednesday allege. And it all happened while Collins was at the annual White House congressional picnic.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
What the chancellor's pension megafund plans mean for your moneyRachel Reeves wants pension schemes to merge and back UK infrastructure – but is it putting your money at risk?
-
Why Māori are protesting in New ZealandA controversial bill has ignited a 'flashpoint in race relations' as opponents claim it will undermine the rights of Indigenous people
-
Crossword: November 21, 2024The Week's daily crossword
-
Boeing machinists approve contract, end strikeSpeed Read The company's largest union approved the new contract offer, ending a seven-week strike
-
US economy still strong in final preelection reportSpeed Read It grew at a solid 2.8% annual rate from July through September
-
Boeing machinists reject deal, continue strikeSpeed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
-
Ports reopen after dockworkers halt strikeSpeed Read The 36 ports that closed this week, from Maine to Texas, will start reopening today
-
Empty-nest boomers aren't selling their big homesSpeed Read Most Americans 60 and older do not intend to move, according to a recent survey
-
Brazil accuses Musk of 'disinformation campaign'Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
-
Disney board fends off Peltz infiltration bidSpeed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
-
Disney and DeSantis reach detenteSpeed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
